Search results
Results from the WOW.Com Content Network
Get excited, because Nestlé is making the entire task a whole lot simpler with their new food line, "Vital Pursuit," for Ozempic user. Skip to main content. 24/7 ...
The company entered the pharmaceutical industry in 1957, initially introducing prescription cough/cold products. In 1987, Pamlab was purchased by Samuel and Judith Camp. [1] In early 2013, Pamlab was purchased by Nestlé Health Science. [2] In December 2016, Pamlab was purchased by Alfasigma Group of Bologna, Italy. [3]
Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing market of consumers who are using GLP-1 drugs like Ozempic and Wegovy.
The Health Science branch has already produced several products, such as drinks and protein shakes meant to combat malnutrition, diabetes, digestive health, obesity, and other diseases. [44] It acquired British pharmaceutical company Vitaflo, which makes clinical nutritional products for people with genetic disorders, in August 2010. [45]
Speaking to Bloomberg, Nestle’s CEO Mark Schneider said the group was working on “companion products” for people using weight-loss aiding drugs to ensure their diet is nutritionally complete.
In 2011, the packaging design and bottle shape of Boost products was changed. [5] Due to increased demand in Boost, Nestlé added another line to its Indiana facility in 2013. [6] In 2015, the brand introduced the Boost Compact range and in 2016 they introduced the Boost Simply range.
The global demand for instant food and beverage products is foreseen to propel the powdered beverage market. Key producers are offering gluten and sugar-free, non-GMO alternatives to powdered drinks, attracting a new consumer base. Innovative flavors and health-benefiting ingredients are being introduced to boost consumption.
Nestle's unit will pay an undisclosed payment to Massachusetts-based Seres, and the drug maker will also receive capital infusions, the companies said. Vowst fits within Nestle Health Science's ...